Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection
Conditions:   EBV;   Epstein-Barr Virus Infection;   Infectious Mononucleosis Interventions:   Biological: EBV gp350-Ferritin Vaccine;   Other: Matrix-M1 Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2020 Category: Research Source Type: clinical trials